Lexington, MA-based Quanterix has developed the Simoa platform, which performs extremely sensitive automated detection and quantification of protein biomarkers. This includes blood biomarkers related to brain injury. 

Quanterix was recognized as one of six final winners in the Head Health Challenge I, sponsored by the NFL and GE, for its efforts to speed diagnosis of mild traumatic brain injuries. 

This summer, Quanterix announced a partnership with fellow winner Banyan Biomarkers that would add Banyan's UCH-L1 and GFAP assays for TBI biomarkers to its Simoa platform.

Learn about "Tapping the Explosion of Offerings in Sensors" at the MD&M Minneapolis Conference, September 21-22.